Well Lead Medical Co., Ltd. (SHA:603309)

Market Cap	3.43B
Revenue (ttm)	1.47B
Net Income (ttm)	215.29M
Shares Out	292.87M
EPS (ttm)	0.74
PE Ratio	15.83
Forward PE	14.29
Dividend	0.50 (4.44%)
Ex-Dividend Date	May 23, 2024

Volume	3,430,560
Average Volume	3,748,778
Open	11.52
Previous Close	11.52
Day's Range	11.45 - 11.72
52-Week Range	9.45 - 14.67
Beta	-0.14
RSI	56.21
Earnings Date	Apr 25, 2025

About Well Lead Medical

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngea...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 2,622
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603309

Financial Performance

In 2023, Well Lead Medical's revenue was 1.39 billion, an increase of 1.79% compared to the previous year's 1.36 billion. Earnings were 192.49 million, an increase of 15.56%.